JD Health (06618.HK): The Board of Directors has authorized and approved a plan to repurchase up to US$1 billion of the Company’s shares in the open market over a period of 48 months from the date of approval.
2026-05-12
JD Health (06618.HK): The Board of Directors has authorized and approved a plan to repurchase up to US$1 billion of the Company’s shares in the open market over a period of 48 months from the date of approval.
